https://orcid.org/0000-0002-0587-591X
References
- Ramalingam TR, Muthu A, Lakshmanan A, et al. Role of high acquisition flow cytometry in the detection of marrow involvement in patients with extramedullary B cell non-Hodgkins lymphoma: a comparison with marrow aspirate cytology, trephine biopsy, and PET. Leuk Lymphoma. 2022;63(11):2589–2596.
- Aren M, Marce S, Jurado R, et al. Flow cytometry to detect bone marrow involvement by follicular lymphoma. Cytom Part B Clin Cytom. 2022;102(6):427–439.
- Sorigue M, Cañamero E, Miljkovic MD. Systematic review of staging bone marrow involvement in B cell lymphoma by flow cytometry. Blood Rev. 2021;47:100778.
- Cheson BD, Fisher RI, Barrington SF, United Kingdom National Cancer Research Institute, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and Non-Hodgkin lymphoma: the lugano classification. J Clin Oncol. 2014;32(27):3059–3068.
- Mozas P, Rivero A, López-Guillermo A. Past, present and future of prognostic scores in follicular lymphoma. Blood Rev. 2021;50:100865.
- Bachy E, Maurer MJ, Habermann TM, et al. A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy. Blood. 2018;132(1):49–58.
- Rutherford SC, Herold M, Hiddemann W, et al. Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA. Blood Adv. 2020;4(8):1589–1593.
- Rutherford SC, Li V, Ghione P, et al. Bone marrow biopsies do not impact response assessment for follicular lymphoma patients treated on clinical trials. Br J Haematol. 2017;179(2):242–245.
- McNamara C, Montoto S, Eyre TA, et al. The investigation and management of follicular lymphoma. Br J Haematol. 2020;191(3):363–381.
- Rutherford SC, Yin J, Pederson L, et al. Relevance of bone marrow biopsies for response assessment in US national cancer institute national clinical trials network follicular lymphoma clinical trials. J Clin Oncol. 2022;41(2):336–342.
- Hofmann B, Welch HG. New diagnostic tests: more harm than good. BMJ. 2017;358:j3314.
- Hawkes EA, Barraclough A, Sehn LH. Limited-stage diffuse large B-cell lymphoma. Blood. 2022;139(6):822–834.
- Dreyling M, Ghielmini M, Rule S, ESMO Guidelines Committee. Electronic address: [email protected], et al. Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(3):298–308.
- Sorigue M, Tuset V, Sancho JM. Treatment of localized-stage follicular lymphoma. Eur J Haematol. 2018;101(2):245–256.
- MacManus MP, Hofman MS, Hicks RJ, et al. Abscopal regressions of lymphoma after Involved-Site radiation therapy confirmed by positron emission tomography. Int J Radiat Oncol Biol Phys. 2020;108(1):204–211.